27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Aemetis (NASDAQ:AMTX) shares are trading higher on Tuesday after the company announced it received an FDA national drug code for its OTC sanitizer products.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Aemetis is an international renewable fuel and biochemicals company focused on the production of advanced renewable fuels & chemicals through the acquisition, development & commercialization of innovative technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates a approximately 60 million gallon per year ethanol production facility located in Keyes, California.
Aemetis's stock traded up 27.07% at $2.11 per share at the time of publication on Tuesday. The stock has a 52-week high of $3.47 and a 52-week low of 37 cents.